Page last updated: 2024-10-29

ifosfamide and Chondrosarcoma, Mesenchymal

ifosfamide has been researched along with Chondrosarcoma, Mesenchymal in 1 studies

Chondrosarcoma, Mesenchymal: A rare aggressive variant of chondrosarcoma, characterized by a biphasic histologic pattern of small compact cells intermixed with islands of cartilaginous matrix. Mesenchymal chondrosarcomas have a predilection for flat bones; long tubular bones are rarely affected. They tend to occur in the younger age group and are highly metastatic. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1456)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paasch, C1
De Santo, G1
Boettge, KR1
Strik, MW1

Other Studies

1 other study available for ifosfamide and Chondrosarcoma, Mesenchymal

ArticleYear
Mesenchymal chondrosarcoma metastasising to the pancreas.
    BMJ case reports, 2018, Dec-31, Volume: 11, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cholangiopan

2018